This paper investigated the effects of storage temperature and duration, urine pH, urea concentration, and preservation on urine human chorionic gonadotropin (hCG) immunoreactivity.
Loss of human chorionic gonadotropin in urine during storage at -20°C.
Lempiäinen A, Hotakainen K, Alfthan H, Stenman UH
Purpose
Conclusion
There was no effect of storing urine for 6 months at 4 or -80˚C on hCG immunoreactivity but it declined significantly in specimens stored at -20˚C. While hCG immunoreactivity declined during storage at -20˚C, hCGβ immunoreactivity tended to increase, indicating that the loss in hCG immunoreactivity was due at least in part to dissociation. The magnitude of the decrease in hCG immunoreactivity was modestly correlated with low urine density and creatinine concentration but not storage duration. The storage-mediated loss of hCG immunoreactivity during storage at -20˚C was also significantly higher at high urea concentrations than low and at low pH (6 or 7) than high pH (9), but was not affected by hCG concentration. Preservation of the urine containing 1.0 mol/L urea with 5 or 10% glycerol was able to partially attenuate the effects of storage at -20˚C on hCG immunoreactivity. Preservation with ethylene diamene (EDA), EDTA, or bovine serum albumin (BSA) did not affect the storage-mediated loss of hCG immunoreactivity in urine containing urea.
Studies (3)
Purpose
This study investigated the effects of storage duration, urine density, and creatinine concentration on the loss of hCG immunoreactivity during long-term storage of urine at -20˚C. Levels of hCG were determined in urine from 74 cancer patients with non-specified hCG producing tumors prior to storage and again after storage at -20˚C for 5-14 years. The range of creatinine and urine density in specimens was not specified.
Summary of Findings
Long- term storage of urine at -20C produced variable results as a 23-100% decline in hCG immunoreactivity was observed in 43 of the 74 specimens while an increase was observed in 24 specimens, and no change was observed in the remaining specimens. The degree of loss was not correlated with storage duration or hCG level, but low urine density and creatinine concentration were modestly correlated with reduced hCG immunoreactivity (r=0.67 and r=0.55, respectively). It was speculated that the increased hCG immunoreactivity was due to specimen concentration due to sublimation during storage which was supported by an increase in density of 6 of 12 urine specimens examined.
Biospecimens
FluidUrinePreservation Types
FrozenNone (Fresh)Diagnoses
NeoplasticNot specifiedNeoplasticGerm CellPlatforms
GlycoproteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level Unspecified densityUnspecified range of creatinine levelsUnspecified range of hCG levelsStorage Storage duration 5-14 years
Purpose
This study investigated the effects of storage for up to 6 months at 4, -20, and -80˚C on hCG immunoreactivity and hCG subunits in multiple specimens of urine from one pregnant woman and single specimens from three pregnant women. Thirteen consecutive urine specimens from a pregnant woman were stored at -20˚C and 4˚C for 60 to 300 days before hCG assay. Urine from 3 healthy, pregnant women was stored at 4, -20, and -80˚C and assayed after 1 week, 1 month, 3 months, and 6 months.
Summary of Findings
When urine from three different pregnant women was stored at -20˚C for 3 months, one specimen lost almost all of the hCG and hCGα immunoreactivity, 80% of the hCGβcf immunoreactivity and 30-40% of the hCGβ immunoreactivity, but hCG immunoreactivity remained relatively stable in the other two specimens. Similarly, 13-77% of hCG immunoreactivity was lost during storage of consecutive urine specimens from an individual, but there was an associated 338% increase in hCGβ immunoreactivity, indicating that the loss of hCG was due to dissociation. When the apparent hCG and hCGβ immunoreactivity were considered together, an average of 86% of the hCG was recovered. The loss of hCG immunoreactivity during storage of consecutive urine specimens from one patients was not correlated with the storage duration (3-10 months).
Although there was no effect of storing urine for 6 months at 4 or -80˚C on hCG or hCGβ immunoreactivity, hCGα immunoreactivity declined in two of three specimens with storage at 4˚C (50% and 30% decline, respectively) and by 70% in one of three specimens stored at -80˚C.
Biospecimens
FluidUrinePreservation Types
FrozenOther PreservativeDiagnoses
PregnantNormalPlatforms
GlycoproteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Time of biospecimen collection 13 collectionsStorage Storage duration 0 days1 month1 week3 months3-10 months6 monthsStorage Storage temperature -20˚C-80˚C4˚CImmunoassay Specific Targeted peptide/protein hCGhCGαhCGβhCGβcf
Purpose
This study investigated the effects of urine pH, urea concentration, and preservative on urine hCG immunoreactivity during uo to a month of storage at -80, -20 and 4˚C . A single urine specimen from a pregnant woman was diluted with urine from a healthy individual to achieve an hCG concentration of 300 pmol/L. The urine was then aliquoted and the pH was adjusted to 6 and 7 with lactic acid and to 9 by adding sodium bicarbonate and 0, 0.2 mol/L, and 1 mol/L urea were added to one aliquot at each pH level. Additionally, urine with a pH of 7.0 was aliquoted to investigate the effects of preservation with glycerol (5% and 10%), EDA (10 and 100 mmol/L), EDTA (5 and 10 mmol/L), and BSA (0.05, 0.1, 0.5, 1 and 5 g/L).
Summary of Findings
When exogenous urea was added to urine, the hCG immunoreactivity declined more rapidly at -20˚C and the authors state after a week of storage at -20˚C, there was almost no immunoreactive hCG left. However, there was no effect of urea on the hCG immunoreactivity in urine stored at 4 or -80˚C. The storage-mediated loss of hCG immunoreactivity was also significantly higher at high urea concentrations than low (P<0.005) and at low pH (6 or 7) than high pH (9) (P=0.031), but was not affected by hCG concentration. Further, the hCG immunoreactivity decrease was accompanied by an increase in hCGβ and hCGα immunoreactivity, but no change in hCGβcf immunoreactivity. Importantly, dilution of the urine did not cause reassociation of the hCG.
Significantly more hCG was detected when urine containing 1.0 mol/L urea was not preserved than when it was preserved with 5 or 10% glycerol before storage at -20˚C for 30 days (9% versus 76% and 72%, P=0.0021, both). However, addition of EDA, EDTA, or BSA did not affect the storage-mediated loss of hCG immunoreactivity in urine containing urea.
Biospecimens
FluidUrinePreservation Types
Other PreservativeFrozenDiagnoses
PregnantNormalPlatforms
GlycoproteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 0 mol/L urea0.2 mol/L urea1.0 mol/L ureaBiospecimen Aliquots and Components pH 679Biospecimen Preservation Type of fixation/preservation BSAEDAEDTAGlycerolStorage Storage duration 0 days30 days7 daysStorage Storage temperature -20˚C-80˚C4˚CImmunoassay Specific Targeted peptide/protein hCGhCGαhCGβhCGβcf